Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02682199 · ClinicalTrials.gov registry record

Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation

A clinical trial of Xerostomia, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
100
Enrollment target
1
Study location

NCT02682199: Completed study of Xerostomia, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT02682199 is a study of Xerostomia that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 100 participants, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02682199, a study of Xerostomia, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.

Conditions Studied

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology - Chapel Hill

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-10
Est. Completion 2018-08-30

What the finished NCT02682199 record still lists

NCT02682199 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher).

The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 0 interventions.

NCT02682199 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02682199 about?

NCT02682199 is a clinical study titled "Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation". The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.

What is the current status of trial NCT02682199?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-10. Estimated completion is 2018-08-30.

What conditions does trial NCT02682199 study?

This clinical trial studies the following conditions: Xerostomia.

Who is sponsoring clinical trial NCT02682199?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02682199 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Xerostomia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02682199's enrollment target sits among peer trials

100 2nd of 13 higher than 11 of 13 other Xerostomia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Xerostomia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02682199, the US trial registry maintained by the National Library of Medicine. NCT02682199 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.